As there are many different therapeutic and prophylactic approaches against SARS-CoV-2, there is a need for a wide array of preclinical and clinical trial diagnostic research methods.
TORONTO (PRWEB) April 14, 2021
As SARS-CoV-2 continues to spread across the globe, pharma and biotech companies remain committed to finding effective vaccines and therapeutics. In order to stay ahead of mutations, the pharma and biotech communities will need to be able to continuously adapt their vaccine and therapeutic strategies. Therefore, it is essential to incorporate a high level of flexibility in clinical trials.
As there are many different therapeutic and prophylactic approaches against SARS-CoV-2, there is a need for a wide array of preclinical and clinical trial diagnostic research methods. In addition, the wealth of data generated by SARS-CoV-2 trials has to be processed, analyzed and evaluated, which emphasizes the importance of biostatistical support to generate valuable insights.
Having supported many SARS-CoV-2 clinical trials, Viroclinics scientific advisors, logistical specialists and bioinformaticians will share their best practices on:
- Validated animal models for SARS-CoV-2 studies, immunogenicity and efficacy testing
- Virology assays: virus titration (titer: TCID50/mL), antiviral assays (IC50)
- Molecular assays: qPCR, next-generation sequencing, whole-genome targeted sequencing, including bioinformatics
- Immunological assays: SARS-CoV-2 Neutralization Assay
- Clinical trial operational support and global logistics services
Register for this webinar to gain key insights into SARS-CoV-2 clinical trials, from early stage, preclinical and clinical research to supply chain support and bioinformatics.
Join experts from Viroclinics-DDL, Carel van Baalen, Director R&D; Rienk Jeeninga, Director Clinical Virology Services; Jeroen Strating, Director Molecular Services, Marc van Pruissen, Director Clinical Trial Operations; and Michiel Weber, Senior Bioinformatician for the live webinar on Friday, April 30, 2021 at 10am EDT (3pm BST/UK).
For more information, or to register for this event, visit Translating SARS-CoV-2 Clinical Trial Challenges Into Lasting Solutions.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.